Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dexlansoprazole 60mg MR + Domperidone 30mg SR Capsule
Therapeutic Category
Antacid, Gastroenterology
Dosage Form
Capsule
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Lanzotyle D Capsules containing Dexlansoprazole and Domperidone are used for the management of acidity, gastroesophageal reflux disease (GERD), nausea, and digestive discomfort. They help provide relief from acid-related gastric symptoms.
Dexlansoprazole works as a proton pump inhibitor that reduces stomach acid production, while Domperidone improves gastric motility and helps relieve nausea and bloating.
The modified-release and sustained-release formulation provides prolonged symptom control and better digestive comfort, making it suitable for long-term gastro care management.
With increasing prevalence of acidity, reflux disorders, and lifestyle-related digestive issues, this product offers strong business potential for retailers and distributors. Its chronic therapy usage, broad prescription demand, and strong consumer acceptance make it a reliable product for growth in the gastroenterology segment.
May cause nausea, diarrhea, headache, abdominal pain, flatulence, or dizziness. Long-term use may lead to bone fractures, vitamin B12 deficiency, or magnesium imbalance.
Used to treat GERD, erosive esophagitis, peptic ulcers, and other acid-related disorders.
Consult a doctor before use, especially if pregnant, breastfeeding, or taking other medications. Avoid prolonged use without medical supervision to prevent potential complications.
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
Composition : Lansoprazole (15mg) Tablet
Composition : Lansoprazole (30mg)
Composition : Omeprazole (20mg) Capsule
Composition : Pantoprazole (20mg)
Composition : Pantoprazole (40mg) Injection
Composition : Pantoprazole (40mg)
Composition : Pantoprazole (80mg) Dual Release Gastro-Resistant
Composition : Pantoprazole (40mg) + Itopride (150mg)
Composition : Rabeprazole I.P. 20mg
Composition : Rabeprazole (20mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Lanzotyle D Capsules, containing Dexlansoprazole 60mg MR and Domperidone 30mg SR, has strong demand in the gastroenterology segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on acid reflux and digestive care portfolios.
Medical distributors and agencies can benefit from the consistent demand for combination gastro-protective therapies used in GERD, acidity, acid reflux, gastritis, nausea, and indigestion management. The modified-release and sustained-release combination helps provide prolonged symptom control, strengthening a comprehensive gastro care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Lanzotyle D Capsules with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong GI prescription demand, repeat patient usage, reliable supply chain support, and good margins when partnering for Lanzotyle D Capsules distribution.
Medical distributors, stockists, and wholesalers interested in Lanzotyle D Capsules can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.